Finance

In this article

A JetBlue passenger jet (Embraer 190) taxis at LaGuardia Airport in New York, New York.
Robert Alexander | Archive Photos | Getty Images

Check out the companies making headlines in midday trading Wednesday.

JetBlue — Shares of JetBlue fell another 7.6% on Wednesday, as investors weighed the airline’s $3.6 billion cash takeover offer to take over rival Spirit Airlines. The move also comes after Raymond James downgraded JetBlue to market perform from outperform. Spirit Airlines shares fell more than 2%.

Eli Lilly — The pharmaceutical stock gained 2.7% after Morgan Stanley named Eli Lilly a top pick. The investment firm said Eli Lilly had the “most robust new product cycle” outlook in the industry.

Tilray — Tilray rose 4.6% after reporting an unexpected profit in its latest quarter. Tilray also announced a deal with supermarket chain Whole Foods, which will sell the hemp powders produced by the company’s Manitoba Harvest subsidiary.

Rivian — Shares of the electric vehicle company fell 5.2% after Rivian said it was on pace to achieve its previously stated production target of 25,000 electric vehicles this year.

Occidental Petroleum — The energy producer’s shares added 1.7% after Stifel initiated coverage with a buy rating. Stifel said Occidental remains ”attractively valued” even after the stock is the best-performing name in the S&P 500 this year.

Intel — Intel’s stock fell 1.8% after the chip maker announced it suspended business operations in Russia. Last month, Intel halted semiconductor shipments to customers in Russia and Belarus.

Twitter — Shares of the social media company fell slightly after rising for three straight days. The stock surged earlier this week, as investors grew optimistic about Elon Musk’s big investment in the company. Musk will join its board of directors and he teased “significant improvements” in the coming months.

— CNBC’s Jesse Pound and Yun Li contributed reporting

Articles You May Like

Home Depot is on the verge of an earnings rebound after quarterly beat and raise
Here’s why tax-loss harvesting can be easier with exchange-traded funds
Amgen says no concerns around weight loss drug’s bone density data after stock falls
Space stocks saw big gains this week in part due to ‘Trump-Elon trade’ rally, analysts say
Megacap tech stocks make some room — here is where investors are branching out